Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3202743 | 1.00 | TP53 (0.32) | TP53PGDLMNAALOX15BLM | |
| SCHEMBL28224690 | 1.00 | TP53 (0.32) | TP53PGDLMNAALOX15BLM | |
| SCHEMBL7152817 | 1.00 | TP53 (0.32) | TP53PGDLMNAALOX15BLM | |
| SCHEMBL30243032 | 1.00 | TP53 (0.32) | TP53PGDLMNAALOX15BLM | |
| SCHEMBL3829374 | 1.00 | TP53 (0.32) | TP53PGDLMNAALOX15BLM | |
| SCHEMBL5051622 | 1.00 | TP53 (0.32) | TP53PGDLMNAALOX15BLM | |
| Hydrochloric Acid SCHEMBL15778876 | 0.97 | TP53 (0.30) | TP53PGD | |
| SCHEMBL18902784 | 0.85 | PGD (0.37) | PGDLMNAALOX15BLMPMP22 | |
| SCHEMBL6686437 | 0.85 | PGD (0.37) | PGDLMNAALOX15BLMPMP22 | |
| SCHEMBL4449219 | 0.85 | PGD (0.37) | PGDLMNAALOX15BLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116693814-A | Block type sugar polymer and preparation method and application thereof | 中国海洋大学 | 2023-09-05 | — | — | CN | claimed |
| CN-116693814-A | Block type sugar polymer and preparation method and application thereof | 中国海洋大学 | 2023-09-05 | — | — | CN | disclosed |
| CN-109553643-A | The application of monosaccharide analog and molecular probe and the molecular probe comprising it | 深圳先进技术研究院 | 2019-04-02 | — | — | CN | disclosed |
| US-9867884-B2 | Vascular delivery systems | BEN-GURION UNIVERSITY OF NEGEV RESEARCH & DEVELOPMENT AUTHORITY (IL) | 2018-01-16 | — | — | US | disclosed |
| EP-2274017-B1 | E-SELECTIN SPECIFIC VASCULAR DELIVERY SYSTEMS | UNIV BEN GURION (IL) | 2016-04-13 | — | — | EP | disclosed |
| US-20150056157-A1 | VASCULAR DELIVERY SYSTEMS | BEN-GURION UNIVERSITY OF NEGEV RESEARCH & DEVELOPMENT AUTHORITY (IL) | 2015-02-26 | — | — | US | disclosed |
| US-8840874-B2 | Vascular delivery systems | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2014-09-23 | — | — | US | disclosed |
| CN-103402525-A | Methods of inhibiting protein fucosylation in vivo using fucose analogs | SEATTLE GENETICS INC | 2013-11-20 | — | — | CN | disclosed |
| US-20120014904-A1 | VASCULAR DELIVERY SYSTEMS | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2012-01-19 | — | — | US | disclosed |
| EP-2274017-A2 | VASCULAR DELIVERY SYSTEMS | Ben Gurion University Of The Negev Research And Development Authority (IL) | 2011-01-19 | — | — | EP | disclosed |
| WO-2009133545-A2 | VASCULAR DELIVERY SYSTEMS | BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2009-11-05 | — | — | WO | disclosed |
| US-5599915-A | INHIBIT SELECTIN-MEDIATED CELLULAR ADHESION | THE SCRIPPS RESEARCH INSTITUTE (US) | 1997-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150056157-A1 | VASCULAR DELIVERY SYSTEMS | SELE, SELPLG, SELL | TP53 1068/4885PGD 2399/4885LMNA 883/4885 |
| US-20120014904-A1 | VASCULAR DELIVERY SYSTEMS | SELE, SELPLG, SELL | TP53 1068/4885PGD 2399/4885LMNA 883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.